In addition, PAI-1 acts as an acute phase protein (APP) during APR such as acute lung injury (ALI), inflammation, and sepsis [7, 21–24] and is closely associated with poor outcome in ALI patients [25, 26]. This evidence concerns the gene APP and acute respiratory distress syndrome.